Pär Fors, CEO of NNIT, comments:
"We are pleased to report solid business performance and stronger financials in the first quarter of 2023 as Life Sciences Solutions and Cloud and Digital Solutions lifted the activity level and improved utilization. We won several new contracts and renewals and remain on track to deliver our 2023 guidance. Equally important, we are thrilled that the divestment of our infrastructure business was completed on April 28, 2023, paving the road for the development of NNIT as a highly specialized IT services provider with two strongly positioned business units”.
Highlights Q1 2023
Financial highlights
Revenue increased YoY by 16% (11% organic) to DKK 413 million in Q1 2023, driven by strong contributions from both business units with particularly solid growth in the two areas Production IT and Custom Application Development.
The operating result before special items increased to DKK 20 million from DKK -16 million positively impacted by growth and improved utilization. The operating profit margin increased to 4.9% compared to -4.5% in Q1 2022.
Special items amounted to DKK 14 million, mainly attributable to earn out payments related to acquisitions following a decision by the Danish Business Authority.
Business highlights
NNIT successfully completed the divestment of the Group’s infrastructure business on April 28, 2023, at a purchase price of DKK 1,350 million (Enterprise Value on a debt free basis) after EBIDTA adjustments. In line with expectations, the estimated cash impact of the transaction, adjusted for net debt and working capital, carve-out and separation costs as well as estimated tax, amounts to DKK 1,288 million including a vendor note of DKK 200 million, which will be repaid no later than six years after closing.
Significant new contracts and renewals secured across Life Sciences Solutions and Cloud & Digital Solutions, including two public contracts and several long-term engagements with international life science customers impacting 2023-2025.
Outlook
NNIT maintains the outlook for growth and operating profit before special items for 2023 with revenue growth of around 10% and operating profit margin before special items expected to increase to around 5% through higher revenue and improved utilization.
NNIT still expects costs of up to DKK 180 million in 2023 relating to carve-out and separation activities as well as earn out payments connected to acquisitions (following a decision by the Business Authority) and restructuring costs to right-size the organization after completion of the strategic divestment of the infrastructure operations. Following closing, NNIT expects to book up to DKK 70 million of these costs as special items with the remaining amount being re-classified as part of discontinued activities.
NNIT is a leading provider of IT solutions to life sciences internationally, and to the public and enterprise sectors in Denmark
We focus on high complexity industries and thrive in environments where regulatory demands and complexity are high.
We advise and build sustainable digital solutions that work for the patients, citizens, employees, end users or customers.
We strive to build unmatched excellence in the industries we serve, and we use our domain expertise to represent a business first approach – strongly supported by a selection of partner technologies, but always driven by business needs rather than technology.
NNIT consists of group company NNIT A/S and subsidiaries SCALES, Excellis Health Solutions and SL Controls. Together, these companies employ more than 1,700 people in Europe, Asia and USA.
Read more at www.nnit.com
NNIT A/S
Lottenborgvej 24
DK2800 Lyngby
Telefon: +45 3077 9578
Telefax: +45 4442-6161
http://www.nnit.com
Senior Communications Consultant
Telefon: +45 (3077) 8337
E-Mail: smst@nnit.com
Head of Public & Media Relations
Telefon: +45 (3077) 9578
E-Mail: tnjh@nnit.com